Xoma | Ativos



Assets Alterar Data
AbbVie USD 135.16B 8.26B 2024-12
Agios Pharmaceuticals USD 1.56B 107.68M 2025-03
Ardelyx USD 435.75M 67.89M 2024-12
BioMarin Pharmaceutical USD 7.15B 158.07M 2025-03
Celldex Therapeutics USD 739.47M 52.87M 2025-03
Eli Lilly USD 89.39B 10.67B 2025-03
Incyte USD 5.75B 305.04M 2025-03
Life Technologies USD 96.83M 5.21M 2024-12
MacroGenics USD 261.65M 2.84M 2024-12
Novartis USD 102.25B 1.28B 2024-12
Novartis USD 102.25B 1.28B 2024-12
Pfizer USD 208.03B 5.37B 2025-03
Prothena USD 547.11M 48.15M 2024-12
Regeneron Pharmaceuticals USD 37.55B 214.2M 2025-03



Xoma Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.